Investors contact

Anders Karlsson, CEO

Email: anders dot karlsson at idogen dot com
Phone: +46 (0) 709 18 00 10

Idogen develops tolerogenic vaccines – long-acting treatment of autoimmune diseases which currently cannot be cured.